started doing people that were younger than 16. you remember their vaccine is for 16 and older. but as you mention, let me show you, this is some of the youngest trial participants that we ve now heard. over 6,000 people age 6 months to 11 years. and then you have 3,000 adolescents, age 12 to 17 years. what s happening now is they re going to trial these, again, very young participants with various doses of the vaccine. 25 micro gram, 50 microgram, 100 mi microgram. they re trying to figure out two things, is this safe in people of that age and what is the right dose to give as well. after that, if those things sort of if they get the information they need and sprois proven safe, they can bridge these trials to existing trials. meaning, hey, we get a lot of information. they could get some results early. as you heard, dr. fauci said by the fall potentially high school students potentially could have a vaccine. i was going to ask you about the timeline there. so if this go